farnesol has been researched along with Benign Neoplasms, Brain in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozdağ Pehlivan, S; Buğdaycı, KE; Demir, T; Kaffashi, A; Karlı Oğuz, K; Koşucu, H; Lüle, S; Mut, M; Sarısözen, C; Söylemezoğlu, F; Vural, İ | 1 |
| Bozdağ Pehlivan, S; Gürsoy-Özdemir, Y; Işıkay, I; Kaffashi, A; Kara, A; Lüle, S; Mut, M; Oguz, KK; Öztürk, N; Sekerdag, E; Söylemezoğlu, F; Vural, I; Yavuz, B | 1 |
| Goldshmit, Y; Kloog, Y; Pinkas-Kramarski, R; Trangle, SS | 1 |
| Cohen, ZR; Daniels, D; Goldberg, L; Kloog, Y; Last, D; Mardor, Y; Ocherashvilli, A; Tamar, G | 1 |
| Aizman, E; George, J; Kloog, Y; Levy, A; Mor, A | 1 |
| Marijnissen, JC; Wang, CH; Xie, J | 1 |
6 other study(ies) available for farnesol and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Farnesylthiosalicylic acid-loaded lipid-polyethylene glycol-polymer hybrid nanoparticles for treatment of glioblastoma.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Farnesol; Female; Glioblastoma; Lipids; Nanoparticles; Polyethylene Glycols; Polymers; Rats; Rats, Wistar; Salicylates; Treatment Outcome; Tumor Burden | 2017 |
A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles.
Topics: Administration, Intranasal; Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Drug Carriers; Drug Delivery Systems; Farnesol; Female; Glioblastoma; Lipids; Magnetic Resonance Imaging; Nanoparticles; Polyesters; Polyethylene Glycols; Rats; Rats, Wistar; Salicylates; Treatment Outcome | 2017 |
Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aptamers, Nucleotide; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Farnesol; Glioblastoma; Humans; Mice, Nude; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; Phosphorylation; ras Proteins; Receptor Cross-Talk; RNA-Binding Proteins; Salicylates; Signal Transduction; Time Factors; Tumor Burden | 2014 |
Salirasib (farnesyl thiosalicylic acid) for brain tumor treatment: a convection-enhanced drug delivery study in rats.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Catheters, Indwelling; Drug Delivery Systems; Farnesol; Magnetic Resonance Imaging; Male; ras Proteins; Rats; Rats, Inbred F344; Salicylates; Signal Transduction | 2008 |
Ras inhibition by FTS attenuates brain tumor growth in mice by direct antitumor activity and enhanced reactivity of cytotoxic lymphocytes.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Farnesol; Forkhead Transcription Factors; Glioma; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Molecular Targeted Therapy; Oncogene Protein v-akt; Proto-Oncogene Proteins p21(ras); ras Proteins; RNA, Messenger; Salicylates; T-Lymphocytes, Cytotoxic; Transforming Growth Factor beta | 2012 |
Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Brain Neoplasms; Calorimetry, Differential Scanning; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Diazonium Compounds; Electrochemistry; Farnesol; G2 Phase; Glioma; Humans; Microscopy, Electron, Scanning; Microspheres; Models, Statistical; Molecular Weight; Paclitaxel; Polymers; Solvents; Spectrometry, X-Ray Emission; Surface Properties; Temperature; Time Factors | 2006 |